slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
16.000
KRW
|
-0,06%
|
|
+1,78%
|
-2,44%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
96.433
|
97.348
|
101.010
|
118.100
|
101.621
|
100.095
|
Bedrijfswaarde
1 |
50.448
|
55.904
|
43.862
|
70.102
|
22.380
|
32.660
|
K/w-verhouding
|
11
x
|
9,55
x
|
828
x
|
34,8
x
|
8,53
x
|
4,68
x
|
Dividendrendement
|
1,58%
|
1,88%
|
1,81%
|
1,29%
|
2,4%
|
-
|
Marktkapitalisatie/omzet
|
1,44
x
|
1,36
x
|
1,88
x
|
2,16
x
|
1,24
x
|
1,03
x
|
Bedrijfswaarde/omzet
|
0,75
x
|
0,78
x
|
0,82
x
|
1,28
x
|
0,27
x
|
0,34
x
|
Bedrijfswaarde/EBITDA
|
4,24
x
|
3,83
x
|
5,61
x
|
7,19
x
|
1,04
x
|
1,19
x
|
Bedrijfswaarde/FCF
|
-
|
4.800.573
x
|
6.626.816
x
|
5.966.798
x
|
1.267.429
x
|
3.390.161
x
|
FCF Yield
|
-
|
0%
|
0%
|
0%
|
0%
|
0%
|
Price to Book
|
0,6
x
|
0,58
x
|
0,61
x
|
0,69
x
|
0,56
x
|
0,5
x
|
Aantal aandelen (in duizenden)
|
6.103
|
6.103
|
6.103
|
6.103
|
6.103
|
6.103
|
Referentieprijs
2 |
15.800
|
15.950
|
16.550
|
19.350
|
16.650
|
16.400
|
Datum van publicatie
|
12-03-20
|
12-03-20
|
22-03-21
|
17-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
66.947
|
71.560
|
53.653
|
54.666
|
81.700
|
97.211
|
EBITDA
1 |
11.899
|
14.604
|
7.821
|
9.747
|
21.440
|
27.395
|
Bedrijfsresultaat (EBIT)
1 |
9.361
|
10.397
|
3.930
|
6.048
|
18.253
|
23.500
|
Operationele Marge
|
13,98%
|
14,53%
|
7,33%
|
11,06%
|
22,34%
|
24,17%
|
Resultaat voor belastingen (EBT)
1 |
11.489
|
13.051
|
1.573
|
5.335
|
18.400
|
28.476
|
Nettowinst (verlies)
1 |
8.801
|
10.197
|
123,9
|
3.392
|
11.912
|
21.374
|
Nettomarge
|
13,15%
|
14,25%
|
0,23%
|
6,2%
|
14,58%
|
21,99%
|
WPA
2 |
1.442
|
1.671
|
20,00
|
555,7
|
1.952
|
3.502
|
Free Cash Flow
|
-
|
11.645
|
6.619
|
11.749
|
17.658
|
9.634
|
FCF-marge
|
-
|
16,27%
|
12,34%
|
21,49%
|
21,61%
|
9,91%
|
Kasstroomconversie (ebitda)
|
-
|
79,74%
|
84,63%
|
120,53%
|
82,36%
|
35,17%
|
Kasstroomconversie (nettowinst)
|
-
|
114,2%
|
5.344,12%
|
346,41%
|
148,24%
|
45,07%
|
Dividend per aandeel
2 |
250,0
|
300,0
|
300,0
|
250,0
|
400,0
|
-
|
Datum van publicatie
|
12-03-20
|
12-03-20
|
22-03-21
|
17-03-22
|
22-03-23
|
20-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
45.985
|
41.444
|
57.148
|
47.998
|
79.241
|
67.435
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
11.645
|
6.619
|
11.749
|
17.658
|
9.634
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
6,2%
|
0,07%
|
2%
|
6,76%
|
11,2%
|
ROA (netto-inkomsten/totale activa)
|
-
|
3,57%
|
1,32%
|
2,04%
|
5,82%
|
6,76%
|
Totale activa
1 |
-
|
285.982
|
9.401
|
166.562
|
204.843
|
316.154
|
Nettoactief per aandeel
2 |
26.363
|
27.550
|
27.245
|
28.185
|
29.593
|
32.846
|
Cashflow per aandeel
2 |
3.674
|
2.130
|
3.014
|
1.308
|
1.503
|
1.478
|
Capex
1 |
2.398
|
492
|
680
|
275
|
239
|
3.820
|
Capex/omzet
|
3,58%
|
0,69%
|
1,27%
|
0,5%
|
0,29%
|
3,93%
|
Datum van publicatie
|
12-03-20
|
12-03-20
|
22-03-21
|
17-03-22
|
22-03-23
|
20-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -2,44% | 72,08 mln. | | +19,98% | 43,48 mld. | | +20,67% | 22,65 mld. | | +14,56% | 14,73 mld. | | +44,72% | 12,04 mld. | | -8,37% | 7,08 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +11,90% | 5,47 mld. | | -2,27% | 4,81 mld. |
Generieke geneesmiddelen
|